Molecular Genetics and Metabolism Reports (Jan 2014)

Diagnosis of ALG12-CDG by exome sequencing in a case of severe skeletal dysplasia

  • Chaya Murali,
  • James T. Lu,
  • Mahim Jain,
  • David S. Liu,
  • Ralph Lachman,
  • Richard A. Gibbs,
  • Brendan H. Lee,
  • Daniel Cohn,
  • Philippe M. Campeau

DOI
https://doi.org/10.1016/j.ymgmr.2014.04.004
Journal volume & issue
Vol. 1, no. C
pp. 213 – 219

Abstract

Read online

Congenital Disorder of Glycosylation type Ig (ALG12-CDG) is part of a group of autosomal recessive conditions caused by deficiency of proteins involved in the assembly of dolichol-oligosaccharides used for protein N-glycosylation. In ALG12-CDG, the enzyme affected is encoded by the ALG12 gene. Affected individuals present clinically with neurodevelopmental delay, growth retardation, immune deficiency, male genital hypoplasia, and cardiomyopathy. A total of six individuals have been reported in the literature. Here, we present an infant with rhizomelic short stature, talipes equinovarus, platyspondyly, and joint dislocations. The infant had marked under-ossification of the pubic bones. Exome sequencing was performed and two deletions, each resulting in a frameshift, were found in ALG12. A review of the literature revealed two infants with ALG12-CDG and a severe skeletal dysplasia, including under-ossification of cervical vertebrae, pubic bones, and knees; in addition to talipes equinovarus and rhizomelic short stature. The phenotype of the individual we describe resembles pseudodiastrophic dysplasia and we discuss similarities and differences between ALG12-CDG and pseudodiastrophic dysplasia. The differential diagnosis in selected undiagnosed skeletal dysplasias should include CDGs.

Keywords